Abstract

Purpose To describe liver imaging reporting and data system (LI-RADS) version 2018 and other MRI imaging features in intrahepatic mass-forming cholangiocarcinoma (iCCA) in Chinese adults with vs. without chronic hepatitis B viral (HBV) infection. Methods We retrospectively enrolled 89 patients with pathologically proven iCCA after multiphase imaging performed between 2004 and 2017 at a tertiary medical center in southern China. Based on whether patients had chronic HBV, iCCA was divided into two subgroups: HBV-positive (n = 50 patients, including 9 with cirrhosis) vs. HBV-negative (n = 39 patients, including 14 with hepatolithiasis and 25 with no identifiable risk factor for iCCA; none had cirrhosis). Two independent abdominal radiologists in consensus reviewed the largest mass in each patient to assign LI-RADS v2018 features; they also scored each observation's shape and location. Imaging features were compared using chi-square or Fisher's exact tests. Results Most iCCAs in HBV-positive (88% (44/50)) and HBV-negative (97% (38/39)) patients had at least one LR-M feature. Compared to iCCAs in HBV-negative patients, iCCAs in HBV-positive patients were more likely to have at least one major feature of HCC (46% (23/50) vs. 8% (3/39), P < 0.001) and more likely to be smooth (42% (21/50) vs. 10% (4/39), P = 0.001). Six of 50 (12%) iCCAs in HBV-positive patients and 1/39 (3%) iCCAs in HBV-negative patients had at least one major feature of HCC without any LR-M feature. Conclusions In this retrospective single-center study in Chinese adults, iCCAs in HBV-positive patients were more likely to resemble HCCs than iCCAs in HBV-negative patients.

Highlights

  • Intrahepatic mass-forming cholangiocarcinoma, a malignancy characterized by cells resembling bile duct epithelium, is the second most common intrahepatic malignancy behind hepatocellular carcinoma (HCC) and accounts for approximately 15% to 20% of all primary liver cancers [1,2,3,4]

  • Our study shows that Intrahepatic mass-forming cholangiocarcinoma (iCCA) display similar imaging features in Chinese adults, regardless of whether the tumors arise in patients with or without underlying hepatitis B viral (HBV) infection: targetoid features manifest with high frequency in both populations. ere was a trend toward less frequent LR-M features and more frequent HCC major

  • Features in the HBV-positive cohort, and a nonnegligible proportion (8%) of iCCAs arising in HBVpositive patients were miscategorized as LR-5 and another 4% were miscategorized as LR-4 or LR-3

Read more

Summary

Introduction

Intrahepatic mass-forming cholangiocarcinoma (iCCA), a malignancy characterized by cells resembling bile duct epithelium, is the second most common intrahepatic malignancy behind hepatocellular carcinoma (HCC) and accounts for approximately 15% to 20% of all primary liver cancers [1,2,3,4]. Risk factors for iCCA depend on geographic region. In China and other East Asian countries, common risk factors. Canadian Journal of Gastroenterology and Hepatology include chronic hepatitis B viral (HBV) infection, hepatolithiasis, and liver fluke infestation, many iCCAs arise in patients without any identifiable risk factors [12,13,14,15,16]. Chronic HBV infection predisposes to HCC development [17], meaning that both iCCA and HCC may arise in the same patient population. Differentiation between iCCA and HCC in such patients is important since the tumors differ in prognosis and management [18, 19]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.